Loading…
Reported covered position: The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; issues and policies related to ensuring tax incentives for employers and individuals to purchase dental coverage; issues and policies related to preserving Medicaid dental coverage; issues and policies related to ensuring a competitive market for dental benefits and allowing purchase of dental benefits as part of a medical policy or on a standalone basis; issues and policies related to ensuring continuity of dental coverage; funding for the Childrens Health Insurance Program; H.R. 1606 - DOC Access Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
APOTEX CORPORATION via BROWN RUDNICK LLP
2017 · second_quarter · Q2
Issues relating to inter parte review challenges.
H.R. 2430 & S. 934-FDA Reauthorization Act of 2017; H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; H.R. 2051 - The FAST Generics Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; issues and policies related to ensuring tax incentives for employers and individuals to purchase dental coverage; issues and policies related to preserving Medicaid dental coverage; issues and policies related to ensuring a competitive market for dental benefits and allowing purchase of dental benefits as part of a medical policy or on a standalone basis; issues and policies related to ensuring continuity of dental coverage; funding for the Childrens Health Insurance Program; H.R. 1606 - DOC Access Act
American Health Care Act of 2017
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: BROWN RUDNICK LLP
issues and policies related to ensuring tax incentives for employers and individuals to purchase dental coverage; H.R. 1628, the American Health Care Act of 2017, provisions related to the business of dental benefits. Yet to be introduced Senate legislation related to repeal of the Affordable Care Act, provisions related to the business of dental benefits.
HR 749 - The Lower Drug Costs Through Competition Act; H.R. 2051 - The FAST Generics Act; S. 297-Increasing Competition in Pharmaceuticals Act; S.469-The Affordable and Safe Prescription Drug Importation Act
H.R. 2051 - The FAST Generics Act; H.R. 2212 & S.974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
H.R. 2430 & S. 934-FDA Reauthorization Act of 2017; H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; H.R. 2051 - The FAST Generics Act.
H.R. 2051 - The FAST Generics Act; H.R. 2212 & S.974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
H.R. 2430 & S. 934-FDA Reauthorization Act of 2017; H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; H.R. 2051 - The FAST Generics Act.
H.R. 2430 & S. 934-FDA Reauthorization Act of 2017; H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; H.R. 2051 - The FAST Generics Act.
Lower Drug Costs through Competition Act
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
HR 749 - The Lower Drug Costs Through Competition Act; H.R. 2051 - The FAST Generics Act; S. 297-Increasing Competition in Pharmaceuticals Act; S.469-The Affordable and Safe Prescription Drug Importation Act
Increasing Competition in Pharmaceuticals Act
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
HR 749 - The Lower Drug Costs Through Competition Act; H.R. 2051 - The FAST Generics Act; S. 297-Increasing Competition in Pharmaceuticals Act; S.469-The Affordable and Safe Prescription Drug Importation Act
Affordable and Safe Prescription Drug Importation Act
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
HR 749 - The Lower Drug Costs Through Competition Act; H.R. 2051 - The FAST Generics Act; S. 297-Increasing Competition in Pharmaceuticals Act; S.469-The Affordable and Safe Prescription Drug Importation Act
H.R. 2430 & S. 934-FDA Reauthorization Act of 2017; H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; H.R. 2051 - The FAST Generics Act.
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: APOTEX CORPORATION · Firm: BROWN RUDNICK LLP
H.R. 2430 & S. 934-FDA Reauthorization Act of 2017; H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; H.R. 2051 - The FAST Generics Act.
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
H.R. 2051 - The FAST Generics Act; H.R. 2212 & S.974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Access to Quality Diabetes Education Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies; H.R.1726 - Access to Quality Diabetes Education Act of 2015
Access to Quality Diabetes Education Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies; H.R.1726 - Access to Quality Diabetes Education Act of 2015
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; Innovations for Healthier Americans
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; S.3056-The CREATES Act
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; S.3056-The CREATES Act; HR 34-21st Century Cures Act
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; S.3056-The CREATES Act
HRC: S.3056-CREATES; HR 34 - 21st Century Cures Act.
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; S.3056-The CREATES Act; HR 34-21st Century Cures Act
Aligning Children's Dental Coverage Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: BROWN RUDNICK LLP
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; H.R. 3463, Aligning Children's Dental Coverage Act" ; S. 3244, Aligning Childrens Dental Coverage Act
Aligning Children's Dental Coverage Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: BROWN RUDNICK LLP
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; H.R. 3463, "Aligning Children's Dental Coverage Act", yet to be introduced Senate companion bill to H.R. 3463
Aligning Children's Dental Coverage Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: BROWN RUDNICK LLP
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; H.R. 3463, Aligning Children's Dental Coverage Act" ; S. 3244, Aligning Childrens Dental Coverage Act
Opioid Review Modernization Act of 2016
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
HR 4981 -Opioid Use Disorder Treatment Expansion and Modernization Act; HR 4976 - Opioid Review Modernization Act of 2016; S. 524 Comprehensive Addiction and Recovery Act (CARA)
Opioid Review Modernization Act of 2016
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
HR 4981 -Opioid Use Disorder Treatment Expansion and Modernization Act; HR 4976 - Opioid Review Modernization Act of 2016; S. 524 Comprehensive Addiction and Recovery Act (CARA)
Opioid Use Disorder Treatment Expansion and Modernization Act
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
HR 4981 -Opioid Use Disorder Treatment Expansion and Modernization Act; HR 4976 - Opioid Review Modernization Act of 2016; S. 524 Comprehensive Addiction and Recovery Act (CARA)
Opioid Use Disorder Treatment Expansion and Modernization Act
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
HR 4981 -Opioid Use Disorder Treatment Expansion and Modernization Act; HR 4976 - Opioid Review Modernization Act of 2016; S. 524 Comprehensive Addiction and Recovery Act (CARA)
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies; H.R.1726 - Access to Quality Diabetes Education Act of 2015
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies; H.R.1726 - Access to Quality Diabetes Education Act of 2015
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies; H.R.1726 - Access to Quality Diabetes Education Act of 2015
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies; H.R.1726 - Access to Quality Diabetes Education Act of 2015
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
S.131 - The FAIR Generics Act; S. 2615 - Increasing Competition in Pharmaceutical Act
Issues relating to GDUFA implementation and pharmaceutical pricing; S.131 - The FAIR Generics Act; S. 2615 - Increasing Competition in Pharmaceutical Act
Increasing Competition in Pharmaceuticals Act
Client: APOTEX CORPORATION · Firm: BROWN RUDNICK LLP
S.131 - The FAIR Generics Act; S. 2615 - Increasing Competition in Pharmaceutical Act
Increasing Competition in Pharmaceuticals Act
Client: APOTEX CORPORATION · Firm: BROWN RUDNICK LLP
Issues relating to GDUFA implementation and pharmaceutical pricing; S.131 - The FAIR Generics Act; S. 2615 - Increasing Competition in Pharmaceutical Act
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; S.3056-The CREATES Act
HRC: S.3056-CREATES; HR 34 - 21st Century Cures Act.
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; S.3056-The CREATES Act
HRC: S.3056-CREATES
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; S.3056-The CREATES Act; HR 34-21st Century Cures Act
Aligning Children's Dental Coverage Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: BROWN RUDNICK LLP
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; H.R. 3463, Aligning Children's Dental Coverage Act" ; S. 3244, Aligning Childrens Dental Coverage Act
Aligning Children's Dental Coverage Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: BROWN RUDNICK LLP
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; H.R. 3463, Aligning Children's Dental Coverage Act" ; S. 3244, Aligning Childrens Dental Coverage Act
Comprehensive Addiction and Recovery Act of 2016
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
HR 4981 -Opioid Use Disorder Treatment Expansion and Modernization Act; HR 4976 - Opioid Review Modernization Act of 2016; S. 524 Comprehensive Addiction and Recovery Act (CARA)
Comprehensive Addiction and Recovery Act of 2016
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
HR 4981 -Opioid Use Disorder Treatment Expansion and Modernization Act; HR 4976 - Opioid Review Modernization Act of 2016; S. 524 Comprehensive Addiction and Recovery Act (CARA)
Consolidated Appropriations Act, 2016
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
H.R.3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 relating to pharmaceutical importation; H.R. 2029 - FY 2016 Consolidated Appropriations Act and the Protecting Americans from Tax Hikes Act of 2015
H.R.6 - 21st Century Cures Act; H.R.2841 - FAST Generics Act of 2015
H.R.2841 - FAST Generics Act of 2015
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; Innovations for Healthier Americans
H.R.6 - 21st Century Cures Act; ; H.R.2841 - FAST Generics Act of 2015; Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
H.R.6 - 21st Century Cures Act; ; H.R.2841 - FAST Generics Act of 2015; CMS Proposed Rule {CMS-1631-P} RIN 0938-AS40 - Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016
Halt Tax Increases on the Middle Class and Seniors Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: BROWN RUDNICK LLP
H.R. 3590 - Patient Protection and Affordable Care Act (implementation and related regulations) H.R. 4872 - Health Care and Education Reconciliation Act (implementation and related regulations)
Halt Tax Increases on the Middle Class and Seniors Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: BROWN RUDNICK LLP
H.R. 3590 - Patient Protection and Affordable Care Act (implementation and related regulations) H.R. 4872 - Health Care and Education Reconciliation Act (implementation and related regulations)
To provide for reconciliation pursuant to section 2002 of the concurrent resolution on the budget for fiscal year 2016.
Client: AMNEAL PHARMACEUTICALS · Firm: BROWN RUDNICK LLP
H.R.3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 relating to pharmaceutical importation; H.R. 2029 - FY 2016 Consolidated Appropriations Act and the Protecting Americans from Tax Hikes Act of 2015
H.R. 3590 - Patient Protection and Affordable Care Act (implementation and related regulations) H.R. 4872 - Health Care and Education Reconciliation Act (implementation and related regulations)
H.R. 3590 - Patient Protection and Affordable Care Act (implementation and related regulations) H.R. 4872 - Health Care and Education Reconciliation Act (implementation and related regulations)
H.R. 6 - The 21st Century Cures Act; Senate Innovations for Healthier Americans; Federal policy relating to GDUFA implementation and pricing of pharmaceuticals
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
H.R.6 - 21st Century Cures Act; ; H.R.2841 - FAST Generics Act of 2015; Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
H.R.6 - 21st Century Cures Act; ; H.R.2841 - FAST Generics Act of 2015; CMS Proposed Rule {CMS-1631-P} RIN 0938-AS40 - Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016
H.R.6 - 21st Century Cures Act; H.R.2841 - FAST Generics Act of 2015
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
Issues relating to diagnostic laboratory testing; H.R. 771, "Protecting Access to Diabetes Supplies;" issues related to regulation of medical electronic data technology
Protecting Access to Diabetes Supplies Act of 2015
Client: ROCHE DIAGNOSTICS CORPORATION · Firm: BROWN RUDNICK LLP
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
2017 · second_quarter · Q2
Yet to be introduced House proposal to have the FDA regulate laboratory developed tests; Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests; Yet to be introduced House proposal on Medicare competitive bidding proposal related to diabetes supplies; Yet to be introduced Senate proposal on Medicare competitive bidding proposal related to diabetes supplies.
Yet to be introduced House proposal to have the FDA regulate laboratory developed tests; Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests; Yet to be introduced House proposal on Medicare competitive bidding proposal related to diabetes supplies; Yet to be introduced Senate proposal on Medicare competitive bidding proposal related to diabetes supplies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via BROWN RUDNICK LLP
2017 · second_quarter · Q2
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; issues and policies related to ensuring tax incentives for employers and individuals to purchase dental coverage; issues and policies related to preserving Medicaid dental coverage; issues and policies related to ensuring a competitive market for dental benefits and allowing purchase of dental benefits as part of a medical policy or on a standalone basis; issues and policies related to ensuring continuity of dental coverage; funding for the Childrens Health Insurance Program; H.R. 1606 - DOC Access Act
issues and policies related to ensuring tax incentives for employers and individuals to purchase dental coverage; H.R. 1628, the American Health Care Act of 2017, provisions related to the business of dental benefits. Yet to be introduced Senate legislation related to repeal of the Affordable Care Act, provisions related to the business of dental benefits.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMNEAL PHARMACEUTICALS via BROWN RUDNICK LLP
2017 · second_quarter · Q2
H.R. 2051 - The FAST Generics Act; H.R. 2212 & S.974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMNEAL PHARMACEUTICALS via BROWN RUDNICK LLP
2017 · first_quarter · Q1
HR 749 - The Lower Drug Costs Through Competition Act; H.R. 2051 - The FAST Generics Act; S. 297-Increasing Competition in Pharmaceuticals Act; S.469-The Affordable and Safe Prescription Drug Importation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via BROWN RUDNICK LLP
2017 · first_quarter · Q1
Yet to be introduced House proposal to have the FDA regulate laboratory developed tests; Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests; Yet to be introduced House proposal on Medicare competitive bidding proposal related to diabetes supplies; Yet to be introduced Senate proposal on Medicare competitive bidding proposal related to diabetes supplies.
Yet to be introduced House proposal to have the FDA regulate laboratory developed tests; Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests; Yet to be introduced House proposal on Medicare competitive bidding proposal related to diabetes supplies; Yet to be introduced Senate proposal on Medicare competitive bidding proposal related to diabetes supplies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via BROWN RUDNICK LLP
2017 · first_quarter · Q1
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; issues and policies related to ensuring tax incentives for employers and individuals to purchase dental coverage; issues and policies related to preserving Medicaid dental coverage; issues and policies related to ensuring a competitive market for dental benefits and allowing purchase of dental benefits as part of a medical policy or on a standalone basis; issues and policies related to ensuring continuity of dental coverage; funding for the Childrens Health Insurance Program; H.R. 1606 - DOC Access Act
issues and policies related to ensuring tax incentives for employers and individuals to purchase dental coverage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via BROWN RUDNICK LLP
2016 · fourth_quarter · Q4
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies; H.R.1726 - Access to Quality Diabetes Education Act of 2015
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via BROWN RUDNICK LLP
2016 · fourth_quarter · Q4
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; H.R. 3463, Aligning Children's Dental Coverage Act" ; S. 3244, Aligning Childrens Dental Coverage Act
Calculation of the advanced premium tax credit as related to the pediatric dental benefit.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
AMNEAL PHARMACEUTICALS via BROWN RUDNICK LLP
2016 · fourth_quarter · Q4
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; S.3056-The CREATES Act; HR 34-21st Century Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via BROWN RUDNICK LLP
2016 · fourth_quarter · Q4
HRC: S.3056-CREATES; HR 34 - 21st Century Cures Act.
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMNEAL PHARMACEUTICALS via BROWN RUDNICK LLP
2016 · third_quarter · Q3
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; S.3056-The CREATES Act
HR 4981 -Opioid Use Disorder Treatment Expansion and Modernization Act; HR 4976 - Opioid Review Modernization Act of 2016; S. 524 Comprehensive Addiction and Recovery Act (CARA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via BROWN RUDNICK LLP
2016 · third_quarter · Q3
HRC: S.3056-CREATES
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via BROWN RUDNICK LLP
2016 · third_quarter · 3A
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies; H.R.1726 - Access to Quality Diabetes Education Act of 2015
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via BROWN RUDNICK LLP
2016 · third_quarter · Q3
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; H.R. 3463, Aligning Children's Dental Coverage Act" ; S. 3244, Aligning Childrens Dental Coverage Act
Calculation of the advanced premium tax credit as related to the pediatric dental benefit.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
ROCHE DIAGNOSTICS CORPORATION via BROWN RUDNICK LLP
2016 · third_quarter · Q3
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via BROWN RUDNICK LLP
2016 · second_quarter · Q2
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
S.131 - The FAIR Generics Act; S. 2615 - Increasing Competition in Pharmaceutical Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMNEAL PHARMACEUTICALS via BROWN RUDNICK LLP
2016 · second_quarter · Q2
HR 4981 -Opioid Use Disorder Treatment Expansion and Modernization Act; HR 4976 - Opioid Review Modernization Act of 2016; S. 524 Comprehensive Addiction and Recovery Act (CARA)
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; S.3056-The CREATES Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via BROWN RUDNICK LLP
2016 · second_quarter · Q2
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; H.R. 6 "21st Century Cures Act"; Not yet introduced Senate proposal on Medicare competitive bidding related to diabetes supplies
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via BROWN RUDNICK LLP
2016 · second_quarter · Q2
Calculation of the advanced premium tax credit as related to the pediatric dental benefit.
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; H.R. 3463, "Aligning Children's Dental Coverage Act", yet to be introduced Senate companion bill to H.R. 3463
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
APOTEX CORPORATION via BROWN RUDNICK LLP
2016 · first_quarter · Q1
Issues relating to GDUFA implementation and pharmaceutical pricing; S.131 - The FAIR Generics Act; S. 2615 - Increasing Competition in Pharmaceutical Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMNEAL PHARMACEUTICALS via BROWN RUDNICK LLP
2016 · first_quarter · Q1
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; Innovations for Healthier Americans
Federal policy relating to abuse deterrent drug development
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via BROWN RUDNICK LLP
2016 · first_quarter · Q1
Calculation of the advanced premium tax credit as related to the pediatric dental benefit.
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
ROCHE DIAGNOSTICS CORPORATION via BROWN RUDNICK LLP
2016 · first_quarter · Q1
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIRACA LIFE SCIENCES via BROWN RUDNICK LLP
2016 · first_quarter · 1T
Proposals related to anatomic pathology and the in-office ancillary services exception to the Ethics in Patient Referrals Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MIRACA LIFE SCIENCES via BROWN RUDNICK LLP
2015 · fourth_quarter · Q4
Proposals related to anatomic pathology and the in-office ancillary services exception to the Ethics in Patient Referrals Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via BROWN RUDNICK LLP
2015 · fourth_quarter · Q4
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit.
Calculation of the advanced premium tax credit as related to the pediatric dental benefit.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
ROCHE DIAGNOSTICS CORPORATION via BROWN RUDNICK LLP
2015 · fourth_quarter · Q4
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMNEAL PHARMACEUTICALS via BROWN RUDNICK LLP
2015 · fourth_quarter · Q4
H.R.3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 relating to pharmaceutical importation; H.R. 2029 - FY 2016 Consolidated Appropriations Act and the Protecting Americans from Tax Hikes Act of 2015
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; Innovations for Healthier Americans
APOTEX CORPORATION via BROWN RUDNICK LLP
2015 · fourth_quarter · Q4
Public Law No: 114-74 relating to generic drug Medicaid inflation rebate
Federal policy relating to federal procurement country of origin requirements for pharmaceuticals
H.R. 6 - The 21st Century Cures Act; Senate Innovations for Healthier Americans; Federal policy relating to GDUFA implementation and pricing of pharmaceuticals
NATIONAL ASSOCIATION OF DENTAL PLANS via BROWN RUDNICK LLP
2015 · third_quarter · 3A
Calculation of the advanced premium tax credit as related to the pediatric dental benefit.
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
ROCHE DIAGNOSTICS CORPORATION via BROWN RUDNICK LLP
2015 · third_quarter · Q3
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIRACA LIFE SCIENCES via BROWN RUDNICK LLP
2015 · third_quarter · Q3
Proposals related to anatomic pathology and the in-office ancillary services exception to the Ethics in Patient Referrals Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via BROWN RUDNICK LLP
2015 · third_quarter · Q3
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit.
Calculation of the advanced premium tax credit as related to the pediatric dental benefit.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
AMNEAL PHARMACEUTICALS via BROWN RUDNICK LLP
2015 · third_quarter · Q3
H.R.2841 - FAST Generics Act of 2015
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94); Issues relating to abuse deterrent drug development
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPIRA, INC. via BROWN RUDNICK LLP
2015 · third_quarter · 3T
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
CMS Proposed Rule {CMS-1631-P} RIN 0938-AS40 - Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via BROWN RUDNICK LLP
2015 · third_quarter · Q3
H.R.6 - 21st Century Cures Act; ; H.R.2841 - FAST Generics Act of 2015; CMS Proposed Rule {CMS-1631-P} RIN 0938-AS40 - Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via BROWN RUDNICK LLP
2015 · second_quarter · Q2
Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via BROWN RUDNICK LLP
2015 · second_quarter · Q2
Calculation of the advanced premium tax credit as related to the pediatric dental benefit.
Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
MIRACA LIFE SCIENCES via BROWN RUDNICK LLP
2015 · second_quarter · Q2
Proposals related to anatomic pathology and the in-office ancillary services exception to the Ethics in Patient Referrals Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMNEAL PHARMACEUTICALS via BROWN RUDNICK LLP
2015 · second_quarter · Q2
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
H.R.6 - 21st Century Cures Act; H.R.2841 - FAST Generics Act of 2015
Issues relating to abuse deterrent drug development
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPIRA, INC. via BROWN RUDNICK LLP
2015 · second_quarter · Q2
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
APOTEX CORPORATION via BROWN RUDNICK LLP
2015 · second_quarter · Q2
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
H.R.6 - 21st Century Cures Act; ; H.R.2841 - FAST Generics Act of 2015; Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via BROWN RUDNICK LLP
2015 · first_quarter · 1A
Issues relating to diagnostic laboratory testing; H.R. 771, "Protecting Access to Diabetes Supplies;" issues related to regulation of medical electronic data technology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via BROWN RUDNICK LLP
2015 · first_quarter · Q1
H.R. 3590 - Patient Protection and Affordable Care Act (implementation and related regulations) H.R. 4872 - Health Care and Education Reconciliation Act (implementation and related regulations)
H.R. 3590 - Patient Protection and Affordable Care Act (implementation and related regulations) H.R. 4872 - Health Care and Education Reconciliation Act (implementation and related regulations)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
AMNEAL PHARMACEUTICALS via BROWN RUDNICK LLP
2015 · first_quarter · Q1
House 21st Century Cures Act Discussion Draft relating to restricted access drug programs
Issues relating to abuse deterrent drug development
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94); Issues relating to ANDA review and approval
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPIRA, INC. via BROWN RUDNICK LLP
2015 · first_quarter · Q1
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via BROWN RUDNICK LLP
2015 · first_quarter · Q1
Implementation of the Biologics Price Competition and Innovation Act (BPCIA); House 21st Century Cures Act Discussion Draft
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Federal policy relating to abuse deterrent drug development
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to medical product cybersecurity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE